Helix

Helix

Private
San Mateo, CaliforniaHealthcare & Life Scienceswww.helix.com

Last Round

Series C

6/3/2021

Total Funding Raised

$383.4M

Company Overview

Helix is a genomics and data analytics company that provides actionable genetic insights and conducts large-scale genetic analysis to enhance patient care and public health decision-making.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Drug Discovery, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Data as a Service, Usage-Based SaaS, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

population genomicsgenomics platformwhole exome sequencingclinico-genomic databasepharmacogenomicsPGxsequencing servicesdrug discoveryreal-world datagenetic screeningviral surveillanceCLIA certified labData as a ServiceDaaSgenetic testingdirect-to-consumer genetic testingDTC genetic testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Helix Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Helix Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series C6/3/2021
Grant7/31/2020
Series B3/1/2018
Series A8/18/2015

Key People

Founding team and executive leadership

Antonio Perez

Chief Executive Officer

Executive Team

James Lu

CEO, Co-Founder, Board Member

Founding Team

Jim Chou

CTO

Executive Team

Sarah Bobulsky

CFO COO

Executive Team

Helix Investors

Notable investors and investment history

InvestorRounds
TemasekSeries B, Series C
NIH RADxGrant
DFJ GrowthSeries B, Series C
Warburg PincusSeries B, Series A, Series C
VenrockSeries B
Kleiner PerkinsSeries B, Series C
Sutter Hill VenturesSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2026

    Partnered with Alnylam Pharmaceuticals for RNAi therapeutics.

  • Feb 10, 2026

    Partnered with Mawi DNA Technologies to expand access to non-invasive DNA collection.

Helix Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Helix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Helix's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Mateo, California
Employee Range577
Year Founded2015
Last Funding6/3/2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.